01/11/2016 - 4:49pm

Miles Harrison joined Galderma U.S. in 2014 from Novartis as VP and general manager, self-medication business unit, which includes Cetaphil. 

01/11/2016 - 12:46pm

Shire and Baxalta, according to a report in Crain’s Chicago Business, will be merging in a deal that is being valued at about $32 billion, which includes a pledge from Shire to give Baxalta Shareholders $18 cash, plus .1282 of Shire’s American depository receipts, per share. The merger will make Shire the largest maker of treatments for rare diseases in the world. (Crain’s Chicago Business)

01/08/2016 - 12:15pm
Mylan’s executive chairman Robert Coury noted that Sheehan has contributed to the company’s financial success since joining, and expressed gratitude for his time. 
01/08/2016 - 11:15am

The Walgreens Flu Index data continues to suggest slight increases in flu activity in a number of markets, including Las Vegas and several markets in the deep South. 

01/07/2016 - 3:48pm

Participation in the newly created Health and Wellness Technology Accelerator is open to companies that support human wellbeing through interventions that target nutrition, physical activity, stress, sleep, alcohol and smoking cessation.

01/06/2016 - 2:53pm

Look for highly targeted, biologically engineered drug therapies and a more integrated, teamwork-driven and evidence-based approach to medication therapy to dominate the pharmacy landscape in 2016.

01/04/2016 - 4:00pm

Drug price concerns were the overriding theme of the microsurvey, with 45% of respondents wanting lower drug prices for patients.

01/04/2016 - 3:52pm

Overall, more than 10,000 community pharmacies nationwide provide med sync services.

01/04/2016 - 3:45pm

About 90% of all specialty drug sales revenue flows through traditional and specialty distributors.